The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

New FDA-Approved Triple-Drug-Regimen for Re-Treatment of Hep C

Back to News Homepage

Next

A New Solution to Relieve Fatigue Caused by Hepatitis C

FDA Approves 1st Treatment of 8 Weeks Duration for All HCV Genotypes

August 7, 2017

Print this page

Learn more about Mavyret, a new Hepatitis C drug that cured more than 92% of the 2,300 patients who were enrolled during clinical trials, in as little as 8 weeks.

FDA approves Mavyret for Hepatitis C

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. Mavyret is also approved for adult patients with HCV genotype 1 infection who have been previously treated with a regimen either containing an NS5A inhibitor or an NS3/4A protease inhibitor but not both.

Mavyret is the first treatment of eight weeks duration approved for all HCV genotypes 1-6 in adult patients without cirrhosis who have not been previously treated. Standard treatment length was previously 12 weeks or more.

Continue reading this entire article:
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm570038.htm

Additional information regarding Mavyret can be found at www.hepatitiscentral.com/mavyret-glecaprevir-pibrentasvir/what-is-mavyret/.

5 Comments
Share
Share

Previous

New FDA-Approved Triple-Drug-Regimen for Re-Treatment of Hep C

Back to News Homepage

Next

A New Solution to Relieve Fatigue Caused by Hepatitis C

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.

  • Michelle Harvey Emmelman

    What is the cost of an 8 week treatment?

  • George Smith

    How much and how do I get it.

    • The Editors

      According to various sources approximately $13,200 per month prior to discounts. See https://www.mavyret.com/ for a downloadable Doctor Discussion Guide as well as information on eligibility for $5 co-pay card.

  • Kenneth Jenkins

    Will it work with Dilantin?

  • Virginia Morrissey

    Well this is misleading from the start – seeing most of us have been previously treated.